RIO DE JANEIRO, BRAZIL - A study, not yet peer-reviewed, conducted by researchers from 12 countries, suggests that the antiparasitic drug could play an important role in reducing Covid-19 deaths.
The group conducted a study known as meta-analysis, which consists of a review of scientific articles already published on the subject worldwide. It included 18 clinical trials involving 2,282 patients.
The finding was that Ivermectin "was associated with the reduction of inflammation markers and faster viral elimination detected in the PCR test."
Also according to the researchers, in six studies involving moderate or severe cases of covid . . .